Anti-ATF3 antibody [EPR22610-19] - ChIP Grade
- RabMAb
- Advanced Validation
- Recombinant
- KO Validated
- What is this?
3
(2 Reviews)
|
(40 Publications)
Anti-ATF3 antibody [EPR22610-19] - ChIP Grade (ab254268) is a rabbit monoclonal antibody detecting ATF3 in Western Blot, Flow Cytometry (Intra), Flow Cytometry, IP, IHC-P, ICC/IF, ChIP. Suitable for Human, Mouse.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 10 publications
View Alternative Names
Cyclic AMP-dependent transcription factor ATF-3, cAMP-dependent transcription factor ATF-3, Activating transcription factor 3, ATF3
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-ATF3 antibody [EPR22610-19] - ChIP Grade (AB254268)
ab254268 staining ATF3 in wild-type Hap1 cells (top panel) and ATF3 knockout Hap1 cells (bottom panel). The cells were fixed with 4% paraformaldehyde (10 min) permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated with ab254268 at 1/100 dilution and ab7291 (Tubulin) at 1/1000 dilution overnight at +4°C, followed by a further incubation at room temperature for 1h with a goat secondary antibody to rabbit IgG (Alexa Fluor® 488) (ab150081) at 2 μg/ml (shown in green) and a goat secondary antibody to mouse IgG (Alexa Fluor® 594) (ab150120) at 2 μg/ml (shown in pseudo color red). Nuclear DNA was labelled in blue with DAPI.
Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ATF3 antibody [EPR22610-19] - ChIP Grade (AB254268)
Immunohistochemical analysis of paraffin-embedded Human placenta tissue labeling ATF3 with ab254268 at 1/500 dilution (1.14 ug/ml) followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP). Nuclear staining in human placenta (PMID/ 28947613). Counterstained with Hematoxylin. Heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0).
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is a ready to use Goat Anti-Rabbit IgG H&L (HRP).
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-ATF3 antibody [EPR22610-19] - ChIP Grade (AB254268)
Intracellular flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized THP-1 (human monocytic leukemia monocyte) treated with 80nM Phorbol 12-myristate 13-acetate (PMA) for 16h, then together with 1μg/ml lipopolysaccharides (LPS) for 8h (Red) / Untreated control (Green) cells labelling ATF3 with ab254268 at 1/600 compared with a Rabbit monoclonal IgG (ab172730) isotype control (Black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat anti rabbit IgG (Alexa Fluor®488, ab150077) at 1/2000 dilution was used as the secondary antibody.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ATF3 antibody [EPR22610-19] - ChIP Grade (AB254268)
Immunohistochemical analysis of paraffin-embedded Human tissue labeling ATF3 with ab254268 at 1/500 dilution (1.14 ug/ml) followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP). Nuclear staining in Reed-Sternberg (HRS) cells of human (PMID : 16263788) is observed. Counterstained with Hematoxylin. Heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0).
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is a ready to use Goat Anti-Rabbit IgG H&L (HRP).
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-ATF3 antibody [EPR22610-19] - ChIP Grade (AB254268)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized THP-1 (human monocytic leukemia monocyte) cells labelling ATF3 with ab254268 at 1/100 (5.7 ug/ml) dilution, followed by ab150077 AlexaFluor® 488 Goat anti-Rabbit secondary antibody at 1/1000 (5.7 ug/ml) dilution (Green). Confocal image showing nuclear staining in THP-1 cells treated with Phorbol 12-myristate 13-acetate (80 nM) for 16 h, then along with lipopolysaccharides (1ug/ml) for 8 h. ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 dilution (Red). The Nuclear counterstain was DAPI (Blue).
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is ab150077 AlexaFluor® 488 Goat anti-Rabbit secondary at 1/1000 (2 ug/ml) dilution.
- ChIP
Unknown
ChIP - Anti-ATF3 antibody [EPR22610-19] - ChIP Grade (AB254268)
Chromatin was prepared from HeLa cells according to the Abcam Dual X-ChIP protocol. Cells were fixed with EGS for 30min, then formaldehyde for 10min. The ChIP was performed with 25 μg of chromatin, 5 μg of ab254268 (red), and 20 μl of Protein A/G sepharose beads. 5 μg of rabbit normal IgG was added to the beads control (gray). The immunoprecipitated DNA was quantified by real time PCR (sybr green approach). Primers and probes are located in the first kb of the transcribed region.
- IP
Unknown
Immunoprecipitation - Anti-ATF3 antibody [EPR22610-19] - ChIP Grade (AB254268)
ATF3 was immunoprecipitated from 0.35 mg RAW264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage) treated with 1ug/ml lipopolysaccharide (LPS) for 2h whole cell lysate 10ug with ab254268 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab254268 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366) was used at 1/1000 dilution.
Lane 1 : RAW264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage) treated with 1ug/ml lipopolysaccharide (LPS) for 2h whole cell lysate 10ug.
Lane 2 : ab254268 IP in RAW264.7 treated with 1ug/ml lipopolysaccharide (LPS) for 2h whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab254268 in RAW264.7 treated with 1ug/ml lipopolysaccharide (LPS) for 2h whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 6 seconds.
All lanes:
Immunoprecipitation - Anti-ATF3 antibody [EPR22610-19] - ChIP Grade (ab254268)
Predicted band size: 21 kDa
Observed band size: 21 kDa
false
- WB
Lab
Western blot - Anti-ATF3 antibody [EPR22610-19] - ChIP Grade (AB254268)
Lanes 1-2 : Merged signal (red and green). Green - ab254268 observed at 21 kDa. Red - loading control ab8245 observed at 37 kDa.
ab254268 Recombinant Anti-ATF3 antibody [EPR22610-19] was shown to specifically react with ATF3 in wild-type A549 cells. Loss of signal was observed when knockout cell line ab266955 (knockout cell lysate ab257075) was used. Wild-type and ATF3 knockout samples were subjected to SDS-PAGE. ab254268 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-ATF3 antibody [EPR22610-19] - ChIP Grade (ab254268) at 1/1000 dilution
Lane 1:
Wild-type A549 cell lysate at 20 µg
Lane 2:
ATF3 knockout A549 cell lysate at 20 µg
Lane 2:
Western blot - Human ATF3 knockout A549 cell line (<a href='/en-us/products/cell-lines/human-atf3-knockout-a549-cell-line-ab266955'>ab266955</a>)
Predicted band size: 21 kDa
Observed band size: 21 kDa
false
- WB
Lab
Western blot - Anti-ATF3 antibody [EPR22610-19] - ChIP Grade (AB254268)
Blocking and dilution buffer : 5% NFDM/TBST.
The expression profile observed is consistent with what has been described in the literature (PMID : 24973221; 24062788).
All lanes:
Western blot - Anti-ATF3 antibody [EPR22610-19] - ChIP Grade (ab254268) at 1/1000 dilution
Lane 1:
Untreated THP-1 (human monocytic leukemia monocyte), whole cell lysate at 20 µg
Lane 2:
THP-1 treated with 80nM TPA overnight, then treated with 1ug/ml lipopolysaccharide (LPS) for 8 hours, whole cell lysate at 20 µg
Lane 3:
Untreated RAW264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage), whole cell lysate at 20 µg
Lane 4:
RAW264.7 treated with 1ug/ml lipopolysaccharide (LPS) for 2 hours, whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 21 kDa
Observed band size: 21 kDa
false
Exposure time: 70s
- WB
Lab
Western blot - Anti-ATF3 antibody [EPR22610-19] - ChIP Grade (AB254268)
Lanes 1-2 : Merged signal (red and green). Green - ab254268 observed at 21 kDa. Red - loading control ab8245 observed at 37 kDa.
ab254268 Recombinant Anti-ATF3 antibody [EPR22610-19] was shown to specifically react with ATF3 in wild-type HCT116 cells. Loss of signal was observed when knockout cell line ab266872 (knockout cell lysate ab257074) was used. Wild-type and ATF3 knockout samples were subjected to SDS-PAGE. ab254268 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-ATF3 antibody [EPR22610-19] - ChIP Grade (ab254268) at 1/1000 dilution
Lane 1:
Wild-type HCT116 cell lysate at 20 µg
Lane 2:
ATF3 knockout HCT116 cell lysate at 20 µg
Lane 2:
Western blot - Human ATF3 knockout HCT116 cell line (<a href='/en-us/products/cell-lines/human-atf3-knockout-hct116-cell-line-ab266872'>ab266872</a>)
Predicted band size: 21 kDa
Observed band size: 21 kDa
false
- WB
Lab
Western blot - Anti-ATF3 antibody [EPR22610-19] - ChIP Grade (AB254268)
Blocking/Diluting buffer and concentration : 5% NFDM/TBST.
Rabbit monoclonal [EPR16891] to GAPDH (ab181602) used as loading control.
ATF3 has a low expression level in some cell lines and tissues, but is increased under treatment (PMID : 8622660, PMID : 22053207, PMID : 20018623, PMID : 29940414).
All lanes:
Western blot - Anti-ATF3 antibody [EPR22610-19] - ChIP Grade (ab254268) at 1/1000 dilution
Lane 1:
293T (Human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Lane 2:
Human liver tissue lysate at 20 µg
Lane 3:
Raw264.7 (Mouse abelson murine leukemia virus-induced tumor macrophage) whole cell lysate at 20 µg
Lane 4:
Mouse liver tissue lysate at 20 µg
Lane 5:
MEF (Mouse embryonic fibroblast (immortalized)) whole cell lysate at 20 µg
Lane 6:
Mouse heart tissue lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 21 kDa
Observed band size: 21 kDa
false
Exposure time: 180s
- WB
Lab
Western blot - Anti-ATF3 antibody [EPR22610-19] - ChIP Grade (AB254268)
Blocking and dilution buffer : 5% NFDM/TBST.
Negative control : Daudi (PMID : 19136462).
The molecular weight observed is consistent with what has been described in the literature (PMID : 18692824).
All lanes:
Western blot - Anti-ATF3 antibody [EPR22610-19] - ChIP Grade (ab254268) at 1/1000 dilution
Lane 1:
HepG2 (human hepatocellular carcinoma epithelial cell), whole cell lysate at 20 µg
Lane 2:
HeLa (human cervix adenocarcinoma epithelial cell), whole cell lysate at 20 µg
Lane 3:
HEK-293T (human embryonic kidney epithelial cell), whole cell lysate at 20 µg
Lane 4:
Daudi (human Burkitts lymphoma lymphoblast), whole cell lysate at 20 µg
Lane 5:
Wild-type HAP1 whole cell lysate at 20 µg
Lane 6:
ATF3 knockout HAP1 whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 21 kDa
Observed band size: 21 kDa
false
Exposure time: 26s
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-ATF3 antibody [EPR22610-19] - ChIP Grade (AB254268)
ChIC/CUT&RUN was performed using a pAG-MNAse at a final concentration of 700 ng/mL. 2.5X10^5 of Human ATF3 knockout HeLa cell line (ab264908) or Human wild-type HeLa cell line (ab255448) were used along with 5µg of Anti-ATF3 antibody (ab254268). Assay Quality Control was conducted using 5µg Anti-CTCF (ab188408) on the same cell lines. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. Additional screenshots of mapped reads can be found in the Protocol booklet in the Product Protocol section. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
Related conjugates and formulations (2)
-
Anti-ATF3 antibody [EPR22610-19] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-ATF3 antibody [EPR22610-19]
Reactivity data
Product details
What is this antibody validated in?
Anti-ATF3 antibody [EPR22610-19] - ChIP Grade (ab254268) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF), ChIP in Human, Mouse samples.
What is the molecular weight of ATF3?
Anti-ATF3 [EPR22610-19] - ChIP Grade (ab254268) specifically detects a band for ATF3 (UniProt: P18847) at a molecular weight of 21kDa.
Trusted by the scientific community
Anti-ATF3 [EPR22610-19] - ChIP Grade (ab254268) was first used in a scientific publication in 2019 and has been cited over 10 times in peer-reviewed journals.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Specificity confirmed
The specificity of Anti-ATF3 antibody [EPR22610-19] - ChIP Grade (ab254268) has been confirmed by Immunocytochemistry testing in ATF3 Knockout HAP1 cell line, ab266955.
Other related products
We have a range of other formats of antibody clone [EPR22610-19] also available for your convenience: ab254268, Carrier free - ab256534, Alexa Fluor® 488 - ab319082
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ATF3 acts as a regulator of cellular stress responses and can influence cell cycle arrest and apoptosis. It does not form a large complex but interacts with diverse partners to execute its functions. Studies often use HCT116 cells to investigate ATF3's role where it can serve as a marker of cellular stress and inflammation. The protein regulates genes involved in maintaining homeostasis in stressed cells.
Pathways
ATF3 is involved in stress response and apoptotic pathways. In the context of apoptosis ATF3 interacts with proteins like p53 and Jun which are important for inducing cell cycle arrest and programmed cell death. In stress response pathways ATF3 modifies transcriptional activity in reaction to various stress signals providing a checkpoint for damaged cells before repairing or entering programmed death.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
- Download chicCutRunSequencingBooklet|en
Target data
Publications (40)
Recent publications for all applications. Explore the full list and refine your search
PloS one 20:e0328530 PubMed40680001
2025
Applications
Unspecified application
Species
Unspecified reactive species
Parasites & vectors 18:245 PubMed40597375
2025
Applications
Unspecified application
Species
Unspecified reactive species
Communications biology 8:920 PubMed40506500
2025
Applications
Unspecified application
Species
Unspecified reactive species
Signal transduction and targeted therapy 10:157 PubMed40360476
2025
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 11:eadq1575 PubMed40184463
2025
Applications
Unspecified application
Species
Unspecified reactive species
Clinical epigenetics 17:9 PubMed39838504
2025
Applications
Unspecified application
Species
Unspecified reactive species
Translational pediatrics 13:2242-2253 PubMed39823004
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of pathology and translational medicine 59:68-83 PubMed39815745
2025
Applications
Unspecified application
Species
Unspecified reactive species
Redox report : communications in free radical research 29:2420563 PubMed39639475
2024
Applications
Unspecified application
Species
Unspecified reactive species
Acta biochimica et biophysica Sinica 57:424-436 PubMed39539109
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com